E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/17/2019 in the Prospect News Bank Loan Daily.

Moody’s rates MyEyeDr. loans B2, Caa2

Moody's Investors Service said it assigned a B3 corporate family rating and a B3-PD probability of default rating to MED ParentCo., LP (MyEyeDr.).

Concurrently, Moody's assigned B2 ratings to the company's proposed first-lien credit facilities and Caa2 ratings to the proposed second-lien credit facilities.

The outlook is stable.

Proceeds from the transaction will be used to fund Goldman Sachs Merchant Banking Division's purchase of MyEyeDr. from Altas Partners and Caisse de dépôt et placement du Québec, and pay for fees and expenses associated with the transaction.

“The secondary buyout doubles the company's debt load compared to the prior capital structure, bringing pro-forma leverage to 8 times on a lease-adjusted basis,” Moody's analyst Raya Sokolyanska said in a news release.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.